\
&
Contact us
\
&
Contact us
Key objectives of the Solar Photovoltaics Partnership include improved R&I collaboration, development of breakthrough PV technologies, and scaling up next-generation solutions to meet European energy transition and policy targets.
- In May 2025, the European Partnership for Solar Photovoltaics (EUPI-PV) was formalised in an MoU between the European Technology & Innovation Platform for Photovoltaics (ETIP PV) and European Commission. Download the MoU on the Partnerships's website: European Partnership for Innovation in Photovoltaics (EUPI-PV) - ETIP PV
- In April 2025, the Partnership published its Strategic Research and Innovation Agenda (SRIA). You can find it here.
info@etip-pv.eu
Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.
Ria.debreucker@vlaio.be
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
